Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BETA CAROTENE FAILS TO REDUCE LUNG CANCER RISK IN HEAVY SMOKERS

This article was originally published in The Tan Sheet

Executive Summary

BETA CAROTENE FAILS TO REDUCE LUNG CANCER RISK IN HEAVY SMOKERS enrolled in a Finnish study of 29,133 male long-term smokers aged 50 to 69 years that appears in the April 14 New England Journal of Medicine. In fact, subjects receiving 20 mg beta carotene daily showed an 18% increase in lung cancer incidence. The clinical trial results on beta carotene and vitamin E supplements for the prevention of lung cancer are the first published analyses of the data from the long-term Alpha- Tocopherol, Beta Carotene (ATBC) Cancer Prevention Study.
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS082675

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel